Advice
Following an abbreviated submission
choriogonadotropin alfa 250mcg/0.5 ml pre-filled syringe (Ovitrelle) is accepted for use in NHS Scotland for use in women undergoing superovulation prior to assisted reproduction techniques such as in vitro fertilisation, where the use of this preparation is appropriate.
Unlike the vial formulation available previously it does not require reconstitution, and the cost per dose is the same.
This replaces advice previously issued by the Scottish Medicines Consortium for Ovitrelle in May 2006 following a non-submission
Download detailed advice30KB (PDF)
Medicine details
- Medicine name:
- choriogonadotropin alfa 250 mcg/0.5 ml pre filled syringe (Ovitrelle)
- SMC ID:
- 263/06
- Indication:
- Superovulation prior to assisted reproductive techniques
- Pharmaceutical company
- Serono Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 October 2006